Akebia Therapeutics (AKBA) Change in Receivables (2013 - 2026)
Akebia Therapeutics (AKBA) reported Change in Receivables of -$9.03 million for Q2 2026, compared with $11.53 million a year earlier.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Change in Receivables (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Akebia Therapeutics' Change in Receivables came in at -$18.59 million; for FY2025, it was $14.14 million.
- By year, Change in Receivables came in at -$4.05 million in FY2024, -$994,000 in FY2023, -$11.3 million in FY2022 and $24.03 million in FY2021.
- Five-year quarterly Change in Receivables spans a low of -$58.73 million in Q3 2022 and a high of $27.87 million in Q1 2025.
- Year over year, Change in Receivables gained in 1 of the last four quarters, with growth averaging 30.2%.
- The high point for year-over-year Change in Receivables in five years was Q2 2024 (growth of 274.0%); the low point was Q2 2023 (a decline of 94.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $15.7 million (Q1 2026), -$19.1 million (Q4 2025) and -$6.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Akebia Therapeutics | 250.00 Mn | -419.48 Mn | 38.70 Mn | -9.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.03 Mn |
| Mar 31, 2026 | 15.70 Mn |
| Dec 31, 2025 | -19.10 Mn |
| Sep 30, 2025 | -6.16 Mn |
| Jun 30, 2025 | 11.53 Mn |
| Mar 31, 2025 | 27.87 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 3.15 Mn |
| Mar 31, 2024 | -12.67 Mn |
| Dec 31, 2023 | 16.70 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 841,000.00 |
| Mar 31, 2023 | -21.55 Mn |
| Dec 31, 2022 | 17.02 Mn |
| Sep 30, 2022 | -58.73 Mn |
| Jun 30, 2022 | 16.64 Mn |
| Mar 31, 2022 | 13.78 Mn |
| Dec 31, 2021 | 1.19 Mn |
| Sep 30, 2021 | 14.69 Mn |
API Access
Akebia Therapeutics Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();